How Do You Treat Toenail Psoriasis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 26, 2021 Category: General Medicine Source Type: news

Scalp Psoriasis Vs Dandruff What Are Differences
Scalp Psoriasis Vs. Dandruff: What Are the Differences? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 26, 2021 Category: General Medicine Source Type: news

Is Egg Good for Psoriasis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 26, 2021 Category: General Medicine Source Type: news

What Does Psoriasis Look Like on Your Hand
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 22, 2021 Category: General Medicine Source Type: news

Difference Between Psoriasis and Plaque
What Is the Difference Between Psoriasis and Plaque Psoriasis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 22, 2021 Category: General Medicine Source Type: news

How Do You Treat Inverse Psoriasis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 22, 2021 Category: General Medicine Source Type: news

Risk for Psoriasis Increased for Cancer Survivors
Increased risks seen for survivors of leukemia, lymphoma, multiple myeloma, skin cancer, and lung cancer in subgroup analyses (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 21, 2021 Category: Cancer & Oncology Tags: Dermatology, Internal Medicine, Oncology, Journal, Source Type: news

Risk for Psoriasis Increased for Cancer Survivors
WEDNESDAY, July 21, 2021 -- Cancer survivors, especially survivors of hematologic malignancies, have an increased risk for psoriasis, according to a research letter published online June 30 in the British Journal of Dermatology. Miri Kim, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 21, 2021 Category: Pharmaceuticals Source Type: news

Johnson & Johnson Reports Q2 2021 Results
New Brunswick, N.J. (July 21, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter. “Our second-quarter results showcase Johnson & Johnson’s diversified portfolio, driven by strong sales and earnings growth across our Medical Device, Consumer Health and Pharmaceutical businesses,” said Alex Gorsky, Chairman and Chief Executive Officer. “I’m so proud of our 136,000 colleagues who remain focused on delivering our medicines and products to patients and consumers around the world, in addition to advancing our pipeline with new product launches and regulato...
Source: Johnson and Johnson - July 21, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

What Causes Psoriasis of the Scalp
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 21, 2021 Category: General Medicine Source Type: news

CBD for Psoriasis and Psoriatic Arthritis: What You Should Know
CBD is growing in popularity, and there are many over-the-counter skin products infused with CBD. While CBD can provide some pain relief to psoriasis and psoriatic arthritis, experts say there needs to be more research. (Source: WebMD Health)
Source: WebMD Health - July 20, 2021 Category: Consumer Health News Source Type: news

What Does a Psoriasis Rash Look Like
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 20, 2021 Category: General Medicine Source Type: news

What Causes Psoriasis on the Hands
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 19, 2021 Category: General Medicine Source Type: news

What Are the Types of Psoriasis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 19, 2021 Category: General Medicine Source Type: news

Questionnaire Responses About Dermatology History Inconsistent
TUESDAY, July 13, 2021 -- Asking people about a history of psoriasis may be useful for assessing psoriasis prevalence, but a similar questionnaire assessing atopic dermatitis does not appear to be as reliable of a method, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2021 Category: Pharmaceuticals Source Type: news

STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
SPRING HOUSE, PENNSYLVANIA, July 9, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new three-year data from the long-term extension (LTE) of the STELARA® (ustekinumab) Phase 3 UNIFI study. The data demonstrated the majority (55.2 percent) of adult patients with moderately to severely active ulcerative colitis (UC) who initially responded to treatment with STELARA sustained symptomatic remissiona rates at nearly three years (week 152).1 Furthermore, a majority (96.4 percent) of the patients in symptomatic remissiona at week 152 were corticosteroid-free. These data are being pr...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Study Provides Insights Into Pediatric Psoriasis Over 20 Years Study Provides Insights Into Pediatric Psoriasis Over 20 Years
Results include evidence that the use of systemic and biologic therapies for pediatric psoriasis have increased over time.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 8, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Ixekizumab vs. Guselkumab in Patients With Plaque Psoriasis Ixekizumab vs. Guselkumab in Patients With Plaque Psoriasis
This phase IV study compared the efficacy of ixekizumab and guselkumab in patients with moderate-to-severe plaque psoriasis. Did one demonstrate superiority over the other?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 7, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Prevalence of Psoriasis 3 Percent in U.S. Population Age 20+
TUESDAY, July 6, 2021 -- The prevalence of psoriasis is 3.0 percent among the U.S. population aged 20 years or older, according to a study published online June 30 in JAMA Dermatology. April W. Armstrong, M.D., M.P.H., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 6, 2021 Category: Pharmaceuticals Source Type: news

New Analysis Puts US Psoriasis Prevalence at 3% New Analysis Puts US Psoriasis Prevalence at 3%
The prevalence rate in adults'continues to place psoriasis as one of the most common immune-mediated diseases affecting adults,'the study authors said.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 3, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

NYUAD study maps nanobody structure, leading to new ways to potentially fight diseases
(New York University) For the first time in the UAE, researchers at NYU Abu Dhabi have used nuclear magnetic resonance techniques to determine the structure of a specific nanobody, Nb23, potentially leading to a better understanding of how this small protein derived from an antibody type, found only in camelids (i.e camels, llamas, and alpacas) and sharks, can fight diseases ranging from rheumatoid arthritis, lupus and psoriasis to lymphoma and breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 2, 2021 Category: Cancer & Oncology Source Type: news

Psoriasis among adults in US
(JAMA Network)What The Study Did:National survey data were used to estimate how common psoriasis is among adults in the United States and how this has changed since 2003. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 30, 2021 Category: International Medicine & Public Health Source Type: news

Biologic Treatment Mitigates PsA Risk in Patients With Psoriasis, Study Finds Biologic Treatment Mitigates PsA Risk in Patients With Psoriasis, Study Finds
The findings suggest that continued treatment with biologic DMARDs'may reduce the risk of incident PsA in patients with moderate to severe chronic plaque psoriasis. 'Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 24, 2021 Category: Rheumatology Tags: Dermatology News Source Type: news

Adults With Psoriasis More Likely to Have Rheumatoid Arthritis
THURSDAY, June 24, 2021 -- Adults with psoriasis have an increased likelihood of having rheumatoid arthritis (RA) compared with adults without psoriasis, according to a study published online June 15 in the Journal of the American Academy of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 24, 2021 Category: Pharmaceuticals Source Type: news

Switching from Western diet to a balanced diet may reduce skin, joint inflammation
(University of California - Davis Health) Diet rich in sugar and fat leads to disruption in the gut's microbial culture and contributes to inflammatory skin diseases such as psoriasis. Research shows that switching to a more balanced diet restores the gut's health and suppresses inflammation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2021 Category: International Medicine & Public Health Source Type: news

Psoriasis and Body Image
People with psoriasis share their experiences and how they learned to manage issues with body image, self-esteem, and quality of life. (Source: WebMD Health)
Source: WebMD Health - June 18, 2021 Category: Consumer Health News Source Type: news

Photobiomodulation: Evaluation in Various Specialties Underway Photobiomodulation: Evaluation in Various Specialties Underway
The therapy is used to treat a wide variety disorders including acne vulgaris, psoriasis, burns, wound healing, and oral mucositis associated with cancer treatment.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 18, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Getting Biologics for Psoriasis: What You Need to Know
Biologic therapy is a breakthrough treatment for psoriasis, but what do you need to know before you try it? One woman shares the ups and downs of her biologics treatment journey. (Source: WebMD Health)
Source: WebMD Health - June 18, 2021 Category: Consumer Health News Source Type: news

Higher BMI Linked to Increased Risk for Developing Psoriasis
WEDNESDAY, June 16, 2021 -- Higher body mass index (BMI) seems to be associated with an increased risk for developing psoriasis, according to a study published online June 9 in the Journal of the American Academy of Dermatology. Alexandra Norden,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 16, 2021 Category: Pharmaceuticals Source Type: news

Living Day to Day With Psoriasis
Lifestyle changes can help improve your psoriasis and your overall health. Follow these expert tips. (Source: WebMD Health)
Source: WebMD Health - June 14, 2021 Category: Consumer Health News Source Type: news

Psoriasis Treatment With Biologics: 5 Things to Know Psoriasis Treatment With Biologics: 5 Things to Know
With a number of these agents available and another pending FDA approval, determining the right drug for your patients may be challenging. Start with these key facts.Medscape Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 14, 2021 Category: Consumer Health News Tags: Dermatology Commentary Source Type: news

Psoriasis: Tips for Wearing Makeup
Some people with psoriasis choose to use makeup. Since this condition can cause skin flakiness and sensitivity, it’s important to be careful when applying makeup. Find out which products to use, what to avoid, and how to use and remove makeup with psoriasis. (Source: WebMD Health)
Source: WebMD Health - June 8, 2021 Category: Consumer Health News Source Type: news

Are Psoriasis and Allergies Linked?
Psoriasis and allergies both cause itchy, skin and both involve immune system reactions. Could they be related? (Source: WebMD Health)
Source: WebMD Health - June 5, 2021 Category: Consumer Health News Source Type: news

Getting Biologics for Psoriasis: What You Need to Know
Biologic therapy is a breakthrough treatment for psoriasis, but what do you need to know before you try it? One woman shares the ups and downs of her biologics treatment journey. (Source: WebMD Health)
Source: WebMD Health - June 4, 2021 Category: Consumer Health News Source Type: news

Dermavant Submits New Drug Application (NDA) to FDA for Tapinarof Cream for the Treatment of Adults with Plaque Psoriasis
LONG BEACH, Calif., and BASEL, Switzerland, June 3, 2021—Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that it has... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - June 3, 2021 Category: Drugs & Pharmacology Source Type: news

Secukinumab, IL-17 Inhibitor, Approved for Pediatric Psoriasis Secukinumab, IL-17 Inhibitor, Approved for Pediatric Psoriasis
' This has changed the playing field for these children and their families completely,'said one pediatric dermatologist at the University of California San Francisco.FDA Approvals (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - June 2, 2021 Category: Pediatrics Tags: Dermatology News Alert Source Type: news

New Phase 3b Psoriatic Arthritis (PsA) Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Robust Joint Symptom Improvement and Complete Skin Clearance in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)
SPRING HOUSE, PENNSYLVANIA, June 2, 2021 – Today the Janssen Pharmaceutical Companies of Johnson & Johnson announced new efficacy and safety data for first-in-class TREMFYA® (guselkumab), including data from the first study evaluating a selective IL-23 inhibitor in adult patients with active PsA, all of whom had demonstrated inadequate response or intolerance to TNFi.1 In the COSMOS Phase 3b study, significantly higher proportions of patients treated with TREMFYA showed joint symptom improvement and complete skin clearance versus placebo at week 24 in this true TNFi-IRa patient population, which is often more...
Source: Johnson and Johnson - June 2, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Novartis Cosentyx Receives FDA Approval for Treatment of Children and Adolescents with Moderate to Severe Plaque Psoriasis
EAST HANOVER, N.J., June 1, 2021 /PRNewswire/ -- Novartis, a leader in immuno-dermatology and rheumatology, today announced the U.S. Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for the treatment of moderate to severe... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 1, 2021 Category: Drugs & Pharmacology Source Type: news

Secukinumab 2-weekly vs. 4-weekly Dosing in Plaque Psoriasis Secukinumab 2-weekly vs. 4-weekly Dosing in Plaque Psoriasis
This study showed a potential benefit of secukinumab dosing every 2 weeks in psoriasis patients who did not respond optimally to secukinumab treatment every 4 weeks.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 28, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Detecting skin disorders based on tissue stiffness with a soft sensing device
(City University of Hong Kong) A research team co-led by a scientist from City University of Hong Kong (CityU) has designed a simple electromechanical device that can be used for deep tissue pathology diagnosis, such as psoriasis, in an automated and non-invasive fashion. The findings will lay a foundation for future applications in the clinical evaluation of skin cancers and other dermatology diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 28, 2021 Category: International Medicine & Public Health Source Type: news

Risk for Autoimmunity Up With Concomitant Vitiligo, Psoriasis
WEDNESDAY, May 26, 2021 -- Individuals with co-occurrence of vitiligo and psoriasis have an increased risk for autoimmunity and family history of psoriasis, according to a research letter published online May 20 in the Journal of the European... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 26, 2021 Category: Pharmaceuticals Source Type: news

Arthritis drug may limit COVID-19 vaccine effectiveness, study finds
COVID-19 vaccines may not be as effective in people who take a drug for rheumatoid arthritis and psoriasis, according to a study published Tuesday by the journal Annals of Rheumatic Diseases. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 25, 2021 Category: Consumer Health News Source Type: news

Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn ’s Disease
SPRING HOUSE, PENNSYLVANIA, May 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohn’s disease (CD) and ulcerative colitis (UC),1-4including data from the SEAVUE study, the first head-to-head study of biologic therapies in patients with CD, presented in a Clinical Science Late-Breaking Abstract Plenary session.1 SEAVUE data showed treatment with STELARA demonstrated high rates of clinical remission, corticosteroid-free remission, clinical response and endoscopic response through one year in biologic-naïve p...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

More Body Surface Area Clearance With Psoriasis Tied to Better Quality of Life
Findings consistent at both six and 12 months of treatment with systemic therapy (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 22, 2021 Category: Psychiatry Tags: Dermatology, Family Medicine, Internal Medicine, Pharmacy, Psychiatry, Journal, Source Type: news

Using'Court Awareness' to Practice More Efficiently Using'Court Awareness' to Practice More Efficiently
' The clinic has been busy lately. Vaccinated patients are returning after a year with their skin cancers that have flourished and psoriasis covering them like kudzu,'said Dr Jeffrey Benabio, on managing his patients.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 21, 2021 Category: Dermatology Tags: Dermatology Commentary Source Type: news

More Body Surface Area Clearance With Psoriasis Tied to Better Quality of Life
FRIDAY, May 21, 2021 -- Greater skin clearance among psoriasis patients is associated with greater improvements in quality of life, according to a letter to the editor published in the June issue of the Journal of the American Academy of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 21, 2021 Category: Pharmaceuticals Source Type: news

Certolizumab Pegol in Psoriasis: Considerations for Pregnancy Certolizumab Pegol in Psoriasis: Considerations for Pregnancy
Is the anti-tumor necrosis factor-alpha agent certolizumab pegol safe to use in pregnant patients? Review the latest data in this article.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Adverse childhood experience in patients with psoriasis - Akamine AA, Rusch GS, Nisihara R, Skare TL.
INTRODUCTION: Adverse childhood experiences (ACEs) have been linked to the occurrence of autoimmune diseases in adults, including psoriasis. AIM: To study the prevalence of ACEs in psoriasis patients comparing it with general population. ME... (Source: SafetyLit)
Source: SafetyLit - May 17, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Scientists show immune cells change behavior unexpectedly to instigate psoriasis lesions
(University of Chicago) Study shows that   when exposed to a trigger, certain kinds of immune cells change their behavior in unexpected ways to produce the protein signals that cause lesions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 13, 2021 Category: International Medicine & Public Health Source Type: news

The Differences Between Eczema and Psoriasis
What Are the Differences Between Eczema and Psoriasis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 11, 2021 Category: General Medicine Source Type: news